Vaccine

Rapid Dose Therapeutics Corp Announces Proposed Equity Private Placement Financing

Burlington, Ontario--(Newsfile Corp. - February 18, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced…

12 months ago

GC376, the Primary Component of Anivive’s Feline Infectious Peritonitis Drug, Nominated by AVMA and FelineVMA to FDA’s List of Bulk Drug Substance for Compounding Office Stock

Nomination could expedite GC376 availability for veterinariansBlack market FIP treatments shown to be unpredictable and dangerousOther organizations are encouraged to…

12 months ago

Foxx Life Sciences Successfully Hosted an Open House Event in Hyderabad

HYDERABAD, India, Feb. 17, 2025 /PRNewswire/ -- Foxx Life Sciences is delighted to announce the successful completion of its Open…

12 months ago

Emmes Group advances data security as ISMS certified ISO compliant

Gold-standard accreditation underscores Emmes Group's commitment to secure and data-rich trials for biotech and pharma partners ROCKVILLE, Md., Feb. 12,…

12 months ago

Terrain Biosciences emerges from stealth to enable faster therapeutics and vaccine development with better RNA

- Founded by Professors Omar Abudayyeh, Jonathan Gootenberg, and Patrick Hsu leveraging novel AI models and technologies for designing, building,…

12 months ago

Dalan Animal Health Unlocks the Power of Innate Immunity for a New Era in Disease Prevention

ATHENS, Ga., Feb. 12, 2025 /PRNewswire/ -- Dalan Animal Health, a global leader in bioscience innovation, today announced a major breakthrough…

12 months ago

Ocugen, Inc. Announces Dosing Completion in the Phase 2 ArMaDa Clinical Trial for OCU410—a Multifunctional Modifier Gene Therapy for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Completed Phase 2 enrollment with randomization of 51 subjects into treatment and control armsPhase 1/2 study (N=60) demonstrated favorable safety…

12 months ago

17 Innovators to be Inducted as the National Inventors Hall of Fame Class of 2025

The Greatest Celebration of American Innovation will be held in Washington, D.C., on May 7-8 NORTH CANTON, Ohio, Feb. 11,…

12 months ago

IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer 

Dr. Faller joins IMUNON with more than 30 years of industry, academic and laboratory experience, with specialized expertise in oncology…

12 months ago

AIM ImmunoTech announces a planned follow-up clinical study evaluating a combination treatment of AIM’s Ampligen® and AstraZeneca’s FluMist® to address the recent avian influenza outbreaks

Planned Investigational New Drug application to expand on previous clinical work at the University of Alabama-Birmingham in which administration of…

1 year ago